Article
Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulation.
BMC infectious diseases - 12 Mar 2015
Lin Carol Y
Abstract excerpt
BACKGROUND: Researchers often group various HPV types into composite measures based on vaccine subtypes, oncogenic potential, or phylogenetic position. Composite prevalence estimates based on PCR genotyping assay results have been calculated to assess HPV infection burden and to monitor HPV vaccine effectiveness. While prevention and intervention strategies can be made based on these prevalence estimates, the...
Topics
- Algorithms
- Computer Simulation
- Genotype
- Humans
- Papillomaviridae
- Papillomavirus Infections
- Papillomavirus Vaccines
- Phylogeny
- Polymerase Chain Reaction
- Prevalence
- United States